King A B, Colligen B H, Levy R A, Cohen K R
Procter & Gamble Pharmaceuticals, Norwich, NY.
J Am Health Policy. 1994 Jul-Aug;4(4):41-5.
The elderly are hit hard by high out-of-pocket expenses for medicines, but a stand-alone pharmaceutical benefit could cost the country billions and still not improve older Americans' quality of care. Such a benefit should be coordinated with patients' overall medical benefits. A systems-based pharmaceutical benefit is financially feasible through a combination of premiums and cost sharing, market-driven price reductions, and cost savings achieved through integrated managed care programs and improved outcomes.
老年人因药品自付费用高昂而深受其害，但一项独立的药品福利可能会让国家花费数十亿美元，而且仍无法改善美国老年人的医疗质量。这样一项福利应该与患者的整体医疗福利相协调。通过保费和费用分摊、市场驱动的降价以及通过综合管理式医疗计划实现的成本节约和改善的治疗效果相结合，基于系统的药品福利在财务上是可行的。
